Caplight Directory>Companies>Nectero Medical-preview>Nectero-medical


Nectero Medical

Nectero Medical

Private
Tempe, ArizonaHealthcare & Life Scienceshttps://www.necteromedical.com

Last Round

Series D

Apr 11, 2024

Total Funding Raised

$115.5M

Momentum Score

25 /100

Company Overview

Nectero Medical is a biotechnology company focused on developing innovative treatments to stabilize and prevent the rupture of mid-sized abdominal aortic aneurysms through the delivery of a stabilizing compound that strengthens vessel walls and allows for safer early intervention.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

AAA treatmentabdominal aortic aneurysmaneurysm stabilizationNectero EAST Systemendovascular therapydrug-device combinationminimally invasive surgerypentagalloyl glucosePGGaortic wall stabilizationimplant-free aneurysm repairvascular surgery deviceEndovascular Aneurysm Stabilization Treatmentdual-balloon catheteractive surveillance alternativeclinical-stage medical devicemedtechBreakthrough Therapy designation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nectero Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nectero Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series DApr 11, 2024
Series CSep 10, 2021
Series BApr 30, 2020
View all Funding Rounds

Nectero Medical Investors

Notable investors and investment history

InvestorRounds
Aphelion CapitalSeries D
Norwest Venture PartnersSeries D
Boston Scientific CorporationSeries D, Series C
Boston Scientific VenturesSeries C, Series D
BioStar CapitalSeries D
Cadence Healthcare VenturesSeries D
View all Investors

Nectero Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nectero Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nectero Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersTempe, Arizona
Employee Range35
Year Founded2019
Last FundingApr 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.